Moderna COVID-19 vaccine may pose higher heart inflammation risk: CDC

Worse then Pfizer’s heart inflammation risk, which is bad enough. Human experimentation on a mass scale. That’s what was done.

Moderna’s COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech’s shot, the U.S. Centers for Disease Control and Prevention said on Tuesday, citing recent data.

Based on data from the Vaccine Safety Datalink (VSD) system, the incidence of heart inflammation was 97.3 cases per million doses for males aged 18-39 following a second dose of Moderna’s shot, versus 81.7 cases per million Pfizer vaccine doses.

Available information suggests that most people with myocarditis after mRNA COVID-19 vaccination recover over time, the CDC said.

You can be sure the figures were much higher- We know that the stats would be limited in number/quantity by arbitrary parameters that would be set to keep these numbers as low as possible- Just the fact of the matter.

No wonder SADS has come to the forefront the last little while

Sudden deaths in young people- heart problems most often to blame

Sudden cardiac death in seemingly healthy people under age 35 is rare. It's more common in males than in females.

Heart In Flamed

Moderna‘s Covid vaccine is more likely than the Pfizer shot to trigger heart inflammation among young and middle-aged men, an analysis has revealed, as the Covid wave is falling on all fronts.

The Centers for Disease Control and Prevention (CDC) found two doses of the largely U.S.-funded shot led to myocarditis and pericarditis in 97.3 cases per million jabs among men aged 18 to 39. For comparison, with the Pfizer shot these cases were recorded at a rate of 81.7.

SADS. Vaccine induced. Looks very possible.

4 replies on “Moderna COVID-19 vaccine may pose higher heart inflammation risk: CDC”

Hope readers take the time to read that link Brian? Thanks

“In October of last year, Health Canada announced that it would be raising the fees it charges to drug manufacturers for new medicines introduced into the market. Historically, Health Canada has used these fees to fund 50% of its operating costs in regulating prescription medication, but plans to raise this to 90% with the coming fee increase. It also plans to provide a 24% rebate if it fails to review new drug applications within the accepted time frame.

Before user fees were introduced in 1994, Health Canada was entirely funded by tax dollars. Now, with the majority of its funding arising directly from the pharmaceutical industry, questions have been raised about whether or not the goal of drug companies to sell their products in vast quantities poses a conflict of interest with Health Canada’s responsibility to provide safe and effective drugs to Canadians.”

It’s a huge conflict of interest!

Leave a Reply

Your email address will not be published. Required fields are marked *